This minimally invasive ablation device shows promise to keep pounds off after GLP-1s

Fractyl Health's Revita system, a minimally invasive hydrothermal ablation device, demonstrated efficacy in maintaining up to 84% of weight loss achieved with GLP-1 medications one year after discontinuation. The single-use catheter targets the duodenal mucosa in the proximal small intestine. The device represents a potential adjunctive approach to weight management following GLP-1 therapy cessation.